Literature DB >> 20781102

Sulphanilamide in the Treatment of Erysipelas.

W R Snodgrass, T Anderson.   

Abstract

Entities:  

Year:  1937        PMID: 20781102      PMCID: PMC2087874          DOI: 10.1136/bmj.2.4014.1156

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  16 in total

1.  Frequentist and Bayesian pharmacometric-based approaches to facilitate critically needed new antibiotic development: overcoming lies, damn lies, and statistics.

Authors:  Paul G Ambrose; Jeffrey P Hammel; Sujata M Bhavnani; Christopher M Rubino; Evelyn J Ellis-Grosse; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

2.  Early endpoints for acute bacterial skin and skin structure infections.

Authors:  George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

Review 3.  Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.

Authors:  Thomas P Lodise; Donald E Low
Journal:  Drugs       Date:  2012-07-30       Impact factor: 9.546

4.  Why the MRC therapeutic trials committee did not introduce controlled clinical trials.

Authors:  Ben Toth
Journal:  J R Soc Med       Date:  2015-12       Impact factor: 5.344

5.  CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections.

Authors:  H David Friedland; Tanya O'Neal; Donald Biek; Paul B Eckburg; Douglas R Rank; Lily Llorens; Alex Smith; Gary W Witherell; Joseph B Laudano; Dirk Thye
Journal:  Antimicrob Agents Chemother       Date:  2012-02-06       Impact factor: 5.191

6.  The use of historical controls and concurrent controls to assess the effects of sulphonamides, 1936-1945.

Authors:  Irvine Loudon
Journal:  J R Soc Med       Date:  2008-03       Impact factor: 5.344

7.  The FDA reboot of antibiotic development.

Authors:  David M Shlaes; Dan Sahm; Carol Opiela; Brad Spellberg
Journal:  Antimicrob Agents Chemother       Date:  2013-07-29       Impact factor: 5.191

8.  UK Medical Research Council and multicentre clinical trials: from a damning report to international recognition.

Authors:  Iain Chalmers
Journal:  J R Soc Med       Date:  2013-12       Impact factor: 5.344

9.  The Medical Research Council and clinical trial methodologies before the 1940s: the failure to develop a 'scientific' approach.

Authors:  Linda Bryder
Journal:  J R Soc Med       Date:  2011-08       Impact factor: 5.344

10.  Systematic Review and Meta-Analysis To Estimate Antibacterial Treatment Effect in Acute Bacterial Skin and Skin Structure Infection.

Authors:  Jordan E Cates; Fanny S Mitrani-Gold; Gang Li; Linda M Mundy
Journal:  Antimicrob Agents Chemother       Date:  2015-05-18       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.